Buscar resultados de ensayos clínicos
Crouzon Syndrome - 4 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2) Condición: Medical Oncology Fecha: 2015-02-16 Intervenciones: Drug: BAY1187982 A dose of 0.1 mg BAY 1187982 per kilogram (kg) body weight (BW) was chosen as the start |
Active, not recruiting |
Nombre del estudio: Phase 1/2 Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations Condición: Solid Tumor Fecha: 2012-12-14 Intervenciones: Drug: ARQ 087 Subjects in this study will receive ARQ 087 orally at dose levels specified for their resp |
Recruiting |
Nombre del estudio: Dovitinib for Gastric Cancer With FGFR2 Amplification Condición: Gastric Cancer Fecha: 2012-10-22 Intervenciones: Drug: Dovitinib
|
Not yet recruiting |
Nombre del estudio: Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients With FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer Condición:
|